Primary Mediastinal (Thymic) Large B-Cell Lymphoma

Explore clinical trials studying Primary Mediastinal (Thymic) Large B-Cell Lymphoma. Study availability and eligibility vary by location and protocol.

5 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Primary Mediastinal (Thymic) Large B-Cell Lymphoma trial results

Recruiting

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

NCT05633615

Conditions: Diffuse Large B-cell Lymphoma, Grade 3b Follicular Lymphoma, Hemic and Lymphatic Diseases, +15 more
Locations: Banner University Medical Center - Tucson Tucson, Arizona, United States

University of Arizona Cancer Center-North Campus Tucson, Arizona, United States

Highlands Oncology Group - Fayetteville Fayetteville, Arkansas, United States

University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

View all 87 locations

View Trial Details

Enrolling by Invitation

Nivolumab and DA-EPOCH-R in Pediatric Primary Mediastinal (Thymic) Large B-cell Lymphoma

NCT06871007

Conditions: Children, Nivolumab, Primary Mediastinal (Thymic) Large B-Cell Lymphoma
Locations: Dmitry Rogachev National Research Center Moscow, Russia

Pavlov University, RM Gorbacheva Research Institute Saint Petersburg, Russia

View Trial Details

Completed

Pembrolizumab and External Beam Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

NCT03210662

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +18 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Dose Adjusted EPOCH-R, to Treat Mature B Cell Malignancies

NCT01760226

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Texas Children's Hospital Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Acalabrutinib and Anti-CD19 CAR T-cell Therapy for the Treatment of B-cell Lymphoma

NCT04257578

Conditions: B-Cell Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Grade 1 Follicular Lymphoma, +17 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Primary Mediastinal (Thymic) Large B-Cell Lymphoma

Primary Mediastinal (Thymic) Large B-Cell Lymphoma trial results

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Nivolumab and DA-EPOCH-R in Pediatric Primary Mediastinal (Thymic) Large B-cell Lymphoma

Pembrolizumab and External Beam Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Dose Adjusted EPOCH-R, to Treat Mature B Cell Malignancies

Acalabrutinib and Anti-CD19 CAR T-cell Therapy for the Treatment of B-cell Lymphoma

Related conditions